Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $81.6 million.

  • SOPHiA GENETICS's Cash & Current Investments fell 1480.05% to $81.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.6 million, marking a year-over-year decrease of 1480.05%. This contributed to the annual value of $123.3 million for FY2024, which is 2359.13% down from last year.
  • Per SOPHiA GENETICS's latest filing, its Cash & Current Investments stood at $81.6 million for Q3 2025, which was down 1480.05% from $94.8 million recorded in Q2 2025.
  • SOPHiA GENETICS's 5-year Cash & Current Investments high stood at $280.6 million for Q3 2021, and its period low was $57.1 million during Q1 2021.
  • Over the past 5 years, SOPHiA GENETICS's median Cash & Current Investments value was $132.8 million (recorded in 2023), while the average stood at $145.3 million.
  • In the last 5 years, SOPHiA GENETICS's Cash & Current Investments skyrocketed by 32638.1% in 2022 and then plummeted by 5026.44% in 2024.
  • Over the past 5 years, SOPHiA GENETICS's Cash & Current Investments (Quarter) stood at $265.3 million in 2021, then decreased by 20.75% to $210.3 million in 2022, then decreased by 23.29% to $161.3 million in 2023, then tumbled by 50.26% to $80.2 million in 2024, then grew by 1.73% to $81.6 million in 2025.
  • Its last three reported values are $81.6 million in Q3 2025, $94.8 million for Q2 2025, and $68.5 million during Q1 2025.